Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhou, Bo
COVID-19, NCT05758675: Study on the Antibody Level Against SARS-CoV-2 （）in Dazhu County in 2023	Recruiting	N/A	20000	RoW		Sinocelltech Ltd.	COVID-19	09/23	12/23
Ting, Huang
SCTV01E, NCT05652543: A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine	Completed	2	518	RoW	SCTV01E, Placebo (normal saline)	Sinocelltech Ltd.	COVID-19 Pandemic	01/24	01/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhou, Bo
COVID-19, NCT05758675: Study on the Antibody Level Against SARS-CoV-2 （）in Dazhu County in 2023	Recruiting	N/A	20000	RoW		Sinocelltech Ltd.	COVID-19	09/23	12/23
Ting, Huang
SCTV01E, NCT05652543: A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine	Completed	2	518	RoW	SCTV01E, Placebo (normal saline)	Sinocelltech Ltd.	COVID-19 Pandemic	01/24	01/24